primaquine phosphate tablet film coated
avera mckennan hospital - primaquine phosphate (unii: h0982hf78b) (primaquine - unii:mvr3634gx1) - primaquine 15 mg
primaquine phosphate tablet
liberty pharmaceuticals, inc. - primaquine phosphate (unii: h0982hf78b) (primaquine - unii:mvr3634gx1) - primaquine phosphate is indicated for the radical cure (prevention of relapse) of vivax malaria. primaquine phosphate is contraindicated in acutely ill patients suffering from systemic disease manifested by tendency to granulocytopenia, such as rheumatoid arthritis and lupus erythematosus. the drug is also contraindicated in patients receiving concurrently other potentially hemolytic drugs or depressants of myeloid elements of the bone marrow. because quinacrine hydrochloride appears to potentiate the toxicity of antimalarial compounds which are structurally related to primaquine, the use of quinacrine in patients receiving primaquine is contraindicated. similarly, primaquine should not be administered to patients who have received quinacrine recently, as toxicity is increased.
primaquine phosphate tablet
aidarex pharmaceuticals llc - primaquine phosphate (unii: h0982hf78b) (primaquine - unii:mvr3634gx1) - primaquine phosphate is indicated for the radical cure (prevention of relapse) of vivax malaria. primaquine phosphate is contraindicated in acutely ill patients suffering from systemic disease manifested by tendency to granulocytopenia, such as rheumatoid arthritis and lupus erythematosus. the drug is also contraindicated in patients receiving concurrently other potentially hemolytic drugs or depressants of myeloid elements of the bone marrow. because quinacrine hydrochloride appears to potentiate the toxicity of antimalarial compounds which are structurally related to primaquine, the use of quinacrine in patients receiving primaquine is contraindicated. similarly, primaquine should not be administered to patients who have received quinacrine recently, as toxicity is increased.
primaquine tablet
sanofi-aventis canada inc - primaquine phosphate - tablet - 26.3mg - primaquine phosphate 26.3mg - antimalarials
primacin primaquine (as phosphate) 7.5mg tablet bottle
boucher & muir pty ltd - primaquine phosphate, quantity: 13.2 mg (equivalent: primaquine, qty 7.5 mg) - tablet, uncoated - excipient ingredients: wheat starch; povidone; purified water; lactose monohydrate; purified talc; gelatin; magnesium stearate; glycerol - prevention of relapses (radical cure) of malaria caused by p.vivax and p. ovale. adjunctive therapy in the treatment of gametocytemia due to p.falciparum in patients resident in areas receptive to malaria.
primaquine phosphate
astrazeneca limited - primaquine phosphate 7.5mg - tablet - 7.5 mg - active: primaquine phosphate 7.5mg
pharmaniaga primaquine tablet 7.5mg
pharmaniaga manufacturing berhad - primaquine phosphate -
primaquine phosphate powder
bluebay shandong co.,ltd - primaquine phosphate (unii: h0982hf78b) (primaquine phosphate - unii:h0982hf78b) -
primaquine phosphate 26.3mg tablet
allied pharma'l labs inc - primaquine phosphate - tablet - 26.3mg
primaquine 7.5mg tablets
special order - primaquine phosphate - oral tablet - 7.5mg